Table 6.
Cumulative Incidences of Postoperative Complications and TTE by Breast Implant
| Breast Implants | N | Censored Values | TTE (mo) |
|---|---|---|---|
| Total (n = 709) | 26 | 683 (96.33) | 27.11 ± 0.64 (25.85–28.37) |
| BellaGel/BellaGel SmoothFine (n = 182) | 1 | 181 (99.45) | 24.82 ± 0.18 (24.47–25.17) |
| Mentor CPG (n = 159) | 5 | 154 (96.86) | 22.15 ± 0.77 (20.64–23.66) |
| Motiva Ergonomix (n = 152) | 10 | 142 (93.42) | 22.23 ± 1.09 (20.10–24.36) |
| Matrix (n = 135) | 7 | 128 (94.81) | 22.12 ± 1.07 (20.03–24.21) |
| Naturgel (n = 61) | 2 | 59 (96.72) | 28.59 ± 1.03 (26.58–30.60) |
| Natrelle 410/510 (n = 20) | 1 | 19 (95.00) | 13.00 ± 0.87 (11.30–14.70) |
Values are represented as mean ± standard error with 95% CI or the number of patients with percentage, where appropriate.
N, incidence of postoperative complications; TTE, time-to-events.